cagrilintide clinical trials VisualAbstract: Combined and semaglutide for weight management well-tolerated in early GLP1 agonists: current and future

February Feb 27: In one of the more closely watched decisions of the first quarter of 2024, the FDA rejected Minerva Neurosciences roluperidone, which had been proposed to treat the negative symptoms of schizophrenia

Progressive adipocyte hypertrophy in aquaporin-7-deficient mice: adipocyte glycerol permeability as a novel regulator of fat accumulation

Unfortunately, its a very expensive treatment that leaves temporary bruises on the skin

this treatment improves immune regulation and limits gland damage (Geetha et al 2023, Phagoora et al

When deficiency is suspected based on clinical features (fatigue, paraesthesia, cognitive changes) or risk factors (vegan diet, gastric surgery, certain medications), serum B12 measurement guides appropriate intervention